STOP antimicrobial

www.baobabcommunication.it
resistance spread
through Quick Diagnostic Methods
and Active Surveillance

“The Alifax screening methods are totally automated, from inoculation of

samples into broths to plating of positive samples on selective agar media;
results can be exhibit within 6 h 30 min, and therefore they reduce the workload
and optimize the laboratory workflow. The rapid recognition of antimicrobial-
resistant organisms is essential to minimize the spread of these bacteria and to
apply the control measures like isolation and monitoring of colonized patients
in critical hospital wards.”
(Mariani S et al. Mic Med 2017)
BELIEVE IN INNOVATION

health Effective screening of colonized or infected samples

care
Patient management optimization
Therapy personalization Bibliography

impact
Patient daily monitoring

M D R O
1- The Bacterial Challenge: Time to React. ECDC/EMEA Joint Technical Report 2009.
Favor the pathology resolution 2- http://www.cdc.gov/drugresistance/
3- Arena F, Giani T, Di Palo MD, Lillo S, Favilli R, Antonelli A, Colavecchio O, Pecile P, Rossolini GM
Evaluation of a new broth-enrichment automated method for rapid detection of intestinal carriage
of carbapenemase-producing Enterobacteriaceae (CPE), ECCMID 2015
4- Marani S, Pedna MF Evaluation of the HB&L carbapenemase and extended spectrum beta Quick and automated phenotypic screening
lactamase-AmpC automated screening kits for the rapid detection of resistant Enterobacteriaceae

laboratory Fully automation in rectal swabs, Microbiologia Medica 2017; 32:6709

5- Urlich WU, Boogen C Study about the performances of a New method: Light scattering rapid
Reduced workloads and hands-on time kinetic detection for MRSA Screening, Private communication 2011.

workflow Optimization of lab workflows 6- Lampert M MRSA Screening with ALIFAX-HBL-culture broth, Private communication 2013
7- Heizmann WR, Magiera C Clinical evaluation of a novel light scattering technology-based assay

Ed00Rev04_04-02-2019
Method standardization for rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) - admission screening of

impact Complete integration of Alifax technology with hospitalized patients, ECCMID 2017
8- Germ J, Saralegui Diez C, Barbic D, Cerar Kisek T, Pirs M Evaluation of detection of carbapenem-

Rev. 28-06-2017
any already present in the lab to provide clinically
resistant Gram-negative bacteria from rectal samples using Alifax HB&L carbapenemase kit,
useful results ECCMID 2017

economic Reduce unnecessary antibiotics

Reduce incidence of infections

impact Reduce the hospitalization cost

BELIEVE IN INNOVATION

ALIFAX MDRO SCREENING KITS are the only phenotypic tests that provide indications regarding
MDRO presence in a few hours with times comparable to those obtained with molecular techniques and ALIFAX S.r.l. Via F. Petrarca, 2/1 - 35020 Polverara - Padova, ITALY
performances superior to direct culture Tel +39 049 0992000 - Fax +39 049 5855434 - info@alifax.com - www.alifax.com
Entered in Padova companies register at the n. 04337640280. Company stock E 10.000.000 entirely deposited Company
with single partner and subjected to direction and coordination of Alifax Holding S.p.A.
Antibiotic
Antibioticresistance
resistance Reliable,
Reliable, fast
fast Fully
Fully
integrated
integrated
technology
technology
Antibiotic
Antibiotic
The
Theglobal
global resistance
resistance
threat
threat Reliable,
Reliable, fast
fastsolution Fully
inFully
in
the
theintegrated
integrated
microbiologytechnology
technology
microbiologylab
lab
The andand complete
complete solution
The global threat
global threat and
and
SCREENING
complete
complete
SCREENING
WITH
WITH
LIGHT
LIGHT
solution
solution
TECHNOLOGY
TECHNOLOGY
in
in the microbiology lab
the microbiology lab
SCREENING WITH LIGHT TECHNOLOGY
SCREENING
SCREENING WITH
WITH LIGHT
LIGHT TECHNOLOGY
TECHNOLOGY 1 1Liquid
Liquid
swabswab
can can
can be
beloaded
be loadedloaded directly
directly intointo
directly Alfred
into 60/AST
Alfred60AST
Alfred60AST
1and Liquid
and Sidecar
Sidecarswab systems
systems
can to
to perform
betoloaded
perform the the
perform
directly the analysis
analysis
intoanalysis by
within a 7
within
Alfred60AST
USA estimated
USA estimated
minimum
minimum
number
number
per year
per year EUROPE
EUROPE
estimated
estimated
minimum
minimum
number
number
per year
per year HB&L CARBAPENEMASE KIT - SI 1001.950 (Liquid Swab) 116h30min
Liquid
and
Liquid swab
hoursSidecar
6h30min
and and can be
streaking
swab loaded
streaking
incubation
can time
be
systems onfor
petri
loaded
to on directly
petri
dishdish
general
directly
perform ofinto
the
ofAlfred60AST
screening
into
the positive
theorpositive
analysis7 within
hours
Alfred60AST
USA estimated minimum number per year EUROPE estimated minimum number per year 60 60 Disposable Disposable
red screw
red screw
cap cap
vialsvials
withwith andin45
culture
culture
and
6h30minSidecar
minutes
fully
in
Sidecarfully systems
for the
automation.
and automation.
streaking
systems toon
to perform
patient the of
petricontrol
perform dish
the analysis
after within
therapy
the positive
analysis within

2.000.000
2.000.000 2.500.000
2.500.000
USA estimated minimum number per year EUROPE estimated minimum number per year
USA estimated minimum number per year EUROPE estimated minimum number per year
EXTRAEXTRA 60 1.8 ml 1.8
ofml
culture
of culture
Disposable broth
red broth
andcap
screw and
2D vials
barcode
2D barcode
with 6h30min
treatment
6h30min
culture and streaking
and streaking
in and
fully streaking on
automation. on petri
on petri dish
petri dish of
dish of the positive
of the positive
2 2UsingUsing
2.000.000 2.500.000
HOSPITAL
HOSPITAL 1 160
60 Disposable
1.8 ml of
Regenerating red
culture
Regenerating screw
solutionbroth
solution cap
and
Disposable red screw cap vials vials with
2D barcode
with the the
culture patented
in fullypatented technology
automation. technology basedbased on onlightlight
culture in fully automation.

2.000.000 2.500.000
EXTRA
ILLNESS
ILLNESS DAYS DAYS
HOSPITAL
EXTRA
HOSPITAL 1.8
10 110 CRERegenerating
CRE ml of culture
supplement
supplement broth
solution and 2D barcode
1.8 ml of culture broth and 2D barcode 2scattering
scattering
Using Alifax
the Alifax
systems
patentedsystems are are
ableable
technology to based
monitor
to monitoronthelight
the
ILLNESS EXTRA
DAYS
HOSPITAL
DAYS 1 11 MIC CRE
10 Regenerating
MIC supplement
CardCard solution 2 Using
2bacteria
bacteria
scattering
Using the
replication
the patented
replicationactivity
Alifax
patentedsystemstechnology
activity
from from
the
technology based
are inoculum
the
ableinoculum
to step
based onintolight
step
monitor
on into
the
light

23.000
23.000 25.000
25.000
ILLNESS HOSPITAL Regenerating solution
DAYS scattering Alifax systems are able to monitor the
ILLNESS DAYS 110 CRE
MIC supplement
Card selective
selective
bacteriaculture
scattering culture
broths
replication
Alifax broths
providing
activity
systems are real
providing
from the
ablereal
time
to time
inoculum growthgrowth
step
monitor into
the

23.000 25.000
10 CRE supplement
11 CARBAPENEMASE
MIC bacteria
curves. replication
curves. replication activity from the inoculum step into
MIC Card
23.000 25.000
DEATHS
DEATHS DEATHS
DEATHS HB&L HB&L CARBAPENEMASE
Card KIT -KIT
SI 1001.950-D
- SI 1001.950-D(Dry(Dry
Swab)
Swab) selective
bacteria culture brothsactivity from the real
providing inoculumtimestepgrowth
into
selective
curves. culture broths providing real time growth
DEATHS
DEATHS
DEATHS
DEATHS
HB&L
HB&L
CARBAPENEMASE
CARBAPENEMASE
KIT
KIT
- SI
-- SI
1001.950-D
1001.950-D
(Dry
Under development. Not CE marked and not FDA registered
(Dry
Swab)
Swab) 3 selective
3Results
Results culture
are reported
curves. are reportedbroths
as negativeproviding
as negative orreal
or positive time
positive growth
withwith
an an
HB&L CARBAPENEMASE KIT SI 1001.950-D (Dry Swab) curves.
DEATHS DEATHS
60 60 Disposable Disposable
red screw
red screw
cap cap
vialsvials
withwith 3estimation
estimation
Results ofare
theofreported
count in CFU/ml.
the count CFU/ml. or positive with an
asinnegative
SHELF
SHELF
LIFELIFE STORAGE
STORAGE 60 2.0 ml 2.0ofml
culture
of culture
Disposable broth
red broth
andcap
screw and
2D vials
barcode
2D barcode
with 3 estimation
3 Results are
Results areof
are reported
reported
reported
the count asnegative
asas negative
CFU/ml.
innegative or
or or positive with
positive.
positive with anan IDENTIFICATION
IDENTIFICATION
WITH
WITH
FromSHELF
From LIFE
production:
production: STORAGE
CONDITIONS
CONDITIONS 1 160
60 Disposable
Disposable red screw cap vials with
Regenerating
Regenerating
2.0 ml of red screw
solution
solution
culture broth cap
and vials
2D barcode
with
4 4Broths
Broths
are in
estimation
estimation
areaseptic
of
of
aseptic
in the vialsvials
count
the count
with
in
with
pierceable
CFU/ml.
in CFU/ml. pierceable
screw screw
cap, cap, MASS
MASS
SPECTROMETRY
SPECTROMETRY
IDENTIFICATION WITH
SHELF LIFE STORAGE
CONDITIONS 10 110 CRE2.0 CRE ml of
of culture
supplement
supplement broth
broth and
and 2D 2D barcode
4thusBroths
thus
considerably
considerably reducing
are in aseptic reducing
contaminations.
vials contaminations.
with pierceable screw cap, IDENTIFICATION WITH
MASS SPECTROMETRY
8 months
8 months
From production:
SHELF LIFE Refrigerated
Refrigerated
STORAGE Regenerating
2.0 ml
1110 MIC Regenerating
solution
culture barcode 4 Broths
4 Broths are
are in
thus considerably
in aseptic vials
reducing
aseptic vials with
with pierceable
contaminations.
pierceable screw
screw cap,
cap,
IDENTIFICATION
MASS
WITH
SPECTROMETRY
From production: CONDITIONS solution 5 5Samples
Carbapenem-resistant
Carbapenem-resistant
Carbapenem-resistant
From8
8
3 days
3
months
From
reconstitution:
reconstitution:
production:
months
days
From
8 months (+4
reconstitution:
Refrigerated
temperature
temperature
CONDITIONS
Refrigerated
(+4
8 °C)
8 °C)
temperature
Refrigerated
1
10
1
10
MIC
CardCard
CRE
CRE
supplement
Regenerating
supplement
MIC Card
CRE supplement
solution Samples
thus
thus
5avoiding
are incubated
avoiding
are incubated
considerably
considerably
sedimentation,
Samples sedimentation,
are incubated
at 37°C
reducing
reducing
at 37°C
flotation
and and
flotation
constantly
and and
at 37°C growth
constantly
contaminations.
contaminations.
growth
mixed
anomalies
constantly
mixed
anomalies
mixed
6h30min
6h30min
MASS SPECTROMETRY

Enterobacteriaceae
Enterobacteriaceae
Carbapenem-resistant
From
3 daysreconstitution:
From reconstitution: temperature
(+4 8 °C)
temperature 11 MIC
MIC Card
Card 5 Samples
typical
typical
of
Samples
avoiding are
several
of incubated
several
are micro-organisms. 37°C and
at 37°C
micro-organisms.
incubated
sedimentation, at
flotation and growth
5 avoiding sedimentation, flotation and growth anomalies constantly
constantly mixed
mixed
anomalies
6h30min
6h30min
Enterobacteriaceae
Enterobacteriaceae
3 days
3 days (+4
(+4 8 8 °C)
°C)
6 avoiding
typical
6The The
bacterial
ofsedimentation,
bacterial
typical
typical
suspension
of several
of severalsuspension
flotation and growth anomalies
several micro-organisms.
obtained
obtained
micro-organisms.
micro-organisms.
at theat the
end end of theof the
RESULT
RESULT
RESULT
Carbapenem-resistant
Carbapenem-resistant
rapidly
rapidly
and and
extensively
Carbapenem-resistant
Carbapenem-resistant
strains
strains
are associated
are
andassociated
Carbapenem-resistant
rapidly
Enterobacteriaceae
extensively
Enterobacteriaceae
worldwide.
worldwide.Invasive
Enterobacteriaceae
Enterobacteriaceae
withwith
extensively high high
mortality
(CRE)
Invasive
mortality
Enterobacteriaceae
worldwide.
(CRE)
havehave
infections
infections
(CRE)
(CRE)
ratesrates
Invasive (up (up
emerged
have
tohave
infections
(CRE)
emerged
withwithCRECRE
emerged
emerged
40-50%)
haveto with
40-50%)
CRE
emerged
HB&LHB&L
HB&L
HB&L
ESBL/AmpC
ESBL/AmpC
ESBL/AmpC
ESBL/AmpC
SCREENING
SCREENING
SCREENING
SCREENING
KIT -KIT
SI 1001.930-L
KIT
KIT
- SI 1001.930-L
- SI
-- SI
(Liquid
1001.930-L
Under development. Not CE marked and not FDA registered
1001.930-L
(Liquid
Swab)
(Liquid
(Liquid
Swab)
Swab)
Swab)
6analysis
6
analysis
The is sufficiently
6confirmatory
The
confirmatory
analysis
The
analysis
phenotypic
phenotypic
analysis
is sufficiently
bacterial
bacterial
biochemical
is
bacterial
is
tests,
confirmatory
enriched
suspension
suspension
biochemical
sufficiently
suspension
sufficiently
is tests,
double-disk
sufficiently
enriched
tests tests
enriched
double-disk
biochemical synergy
to perform
obtained
obtained
synergy
tests
enriched as
toat perform
as oxidase
enriched
obtainedas to
to
at
test,
the end
the
perform
test,
gradient
oxidase
to
further
test,end
oxidase
at perform
the test,
gradient
perform test,
further
either
end
of the
of the
either
further
of the
further
test, test,
either
further
RESULT
HB&L ESBL/AmpC SCREENING KIT SI 1001.930-L (Liquid Swab) confirmatory biochemical tests as
thusrapidly
thus and
emphasizing extensively
emphasizing
strains
rapidly are the need
andassociatedthe need
extensively worldwide.
for
with active
for active
high
worldwide. Invasive
surveillance infections
surveillance
mortality
Invasive programs
rates programs
(up
infections with
toaimed CRE
aimed
40-50%)
with CRE 60 60 Disposable Disposable
greengreen
screw
screw
cap cap
vialsvials
withwith broth
broth
microdilution
microdilution
phenotypic
confirmatory tests, and and
microorganism
double-disk
biochemical tests as oxidase
microorganism
synergy oxidase test,
test, either
identification
test,identification
gradient test,
either
strains
at preventing are
at preventingassociated with high mortality rates (up to 40-50%) 60 1.8 ml 1.8ofml
culture
of culture
Disposable broth
greenbroth
and
screwand
2Dcap
barcode
2Dvials
barcode
with phenotypic
through
through
broth moleculartests,
molecular
microdilution
phenotypic double-disk
biology
andbiology
tests, double-disk synergy
orsynergy test,
proteomic
or proteomic
microorganism gradient
based
gradient test,
based
test,identificationtest,
thus arethe
emphasizing
strains spread
the the
associatedspread
especially
withespecially
need for inmortality
the
active
high in hospital
the rates
hospital
surveillance environment.
environment.
programs
(up aimed
to 40-50%) POSITIVE
POSITIVE
SAMPLE
SAMPLE
Thesethus
These
at emphasizing
programs
thus programs
preventingrely
emphasizingtheonthe
rely need
early
on
spread
the early
need andfor active
and
accurate surveillance
accurate
especially
for active indetection ofprograms
thedetection
hospital
surveillance aggressive
of aimed
aggressive
environment.
programs aimed 1 160
60 Disposable
Disposable green screw cap vials with
Regenerating
Regenerating
1.8 ml of green
solution
culture screw
solution
broth cap
and 2D vials
barcode
with broth
technologies
broth microdilution
technologies
through (Maldi-Tof).
microdilution and
(Maldi-Tof).
molecular and microorganism
biology or proteomic
microorganism identification
based
identification STREAKING
STREAKING
POSITIVE SAMPLE
1.8 ml
ml of
of culture
culture broth and
and 2D
2D barcode
barcode through molecular biology
at
pathogenspreventing
pathogens
These
at resistant
programs
preventing the
resistant
to
the spread
the
rely toclass
onthe
spread especially
class
earlyofand in
carbapenems
ofaccurate
especially the
carbapenems hospital
such
in thedetectionsuch environment.
as imipenem
hospital asaggressive
of imipenem
environment. 10 110 ESBL/AmpC ESBL/AmpC
1.8 supplement
Regenerating supplement
broth
solution technologies
through biology or
(Maldi-Tof).
molecular or proteomic
proteomic based based POSITIVE
POSITIVE SAMPLE
STREAKINGSAMPLE
and These
and programs
meropenem
meropenem
pathogens
These whichrely
which
resistant
programs rely on
are
to early
in
ontheare inand
many
class
early accurate
many
and cases
of the detection
cases last
carbapenems
accurate the line
last
such
detection ofof
line aggressive
therapy
as
of of therapy
imipenem
aggressive 1 11 MIC ESBL/AmpC
10 Regenerating
MIC
CardCard
Regenerating solution
solution
supplement technologies (Maldi-Tof).
technologies (Maldi-Tof). STREAKING
STREAKING
pathogens resistant to the class of carbapenems such as imipenem 10
110 ESBL/AmpC
ESBL/AmpC
MIC Card supplement
supplement
for Gram
for Gram
and negative
pathogens negative
meropenem infections.
resistant infections.
which
to theareclass
in many cases the last
of carbapenems suchline
asof therapy
imipenem
and meropenem
for Gram
and negativewhich
meropenem are
are in
infections.
which in many
many cases
cases the
the last
last line
line of
of therapy
therapy
HB&L11 MIC Card
MIC Card
ESBL/AmpC SCREENING KIT - SI 1001.930 (Dry Swab)
for
for Gram
Gram negative
negative infections.
infections. 60 60 Disposable Disposable
greengreen
screw
screw
cap cap
vialsvials
withwith

ESBL/AmpC
ESBL/AmpC 60 2.0 ml
160
2.0ofmlculture
of culture
Disposable
Disposable
broth
green broth
and and
screw 2D barcode
cap2D barcode
vials
Disposable green screw cap vials with
green screw cap vials
with

ESBL/AmpC SHELF
SHELF
LIFELIFE STORAGE
STORAGE 1 60 Regenerating
Regenerating
2.0 ml of solution
solution
culture broth and 2D barcode
with
ESBL/AmpC
Enterobacteriaceae
Enterobacteriaceae
Enterobacteriaceae
nosocomial
nosocomial and and
spp. spp.
are one
are one
of the
spp. are one of
community-acquired
community-acquired
of most
the most
important
important
theinfections.
mostStrong
infections. important
causes
Strong
causes
of of
causes
selection of
selection
FromSHELF
From
production:
SHELF
8 months
production:
8 months
From
SHELF
LIFE
LIFE
production:
LIFE
CONDITIONS
CONDITIONS
STORAGE
STORAGE
Refrigerated
Refrigerated
CONDITIONS
STORAGE
10 110 ESBL/AmpC
1 10
10
2.0 ml
MIC
ml of
11 MIC ESBL/AmpC
of supplement
ESBL/AmpC
2.0
Regenerating
Regenerating
CardCard
Regenerating
ESBL/AmpC
culture broth and
supplement
culture broth
solution
solution
solution
supplement
supplement
and 2D
2D barcode
barcode

From
FromFrom production:
8 reconstitution: CONDITIONS
reconstitution:temperature
months
production: temperature
Refrigerated
CONDITIONS 110 ESBL/AmpC
MIC Card supplement
Enterobacteriaceae
Enterobacteriaceae spp. are one of the most important causes of
nosocomial
pressure
pressureexerted and
exertedby spp. are
antimicrobial
by one
community-acquired
antimicrobial of
use,the
use,most
especiallyimportant
infections.
especiallyStrong
with causes
withselection
newer-
newer-
nosocomial and
of 8
7 daysmonths
7 days
From
8 reconstitution:(+4 Refrigerated
months (+4
8 °C)8 °C)
temperature
Refrigerated 11 MIC Card
MIC Card
pressure
generation
generation
nosocomial and community-acquired
exerted
ß-lactam
ß-lactam by antibiotics,
antimicrobial
antibiotics, has has
community-acquired infections.
leduse,
to especially
led the
to the Strong withselection
proliferation
infections. newer-
proliferation
Strong of of
selection From
pressure
generation exerted
ß-lactam by antimicrobial use, especially with newer- 7 daysreconstitution:
From reconstitution: temperature
(+4 8 °C)
temperature
bacteria
bacteria
carrying
pressure carrying
enzyme
exerted by antibiotics,
enzymeable able to has
to hydrolyze
antimicrobial ledand
hydrolyze
use, to and
the inactivate
proliferation
inactivate
especially them.
with of
them.
newer- 7
generation 7 days
days (+4
(+4 8 8 °C)
°C)
generation ß-lactam antibiotics, has led to the proliferation of
The bacteria
The
research
research
of ß-lactam
carrying
the
of enzyme
presence
the antibiotics,
presence able
of to has
resistant
of led
hydrolyze
resistant to
bacteria the
and
bacteria
from proliferation
inactivate
from
a swab
a them.
swab
is is
of HB&LHB&L MRSA MRSA
KIT -KIT
SI 1001.900-L
- SI 1001.900-L(Liquid
(Liquid
Swab)Swab)
bacteria
The
a practice
a practice carrying
research
widely of
widely
used enzyme
the presence
used
in able
diagnostic
in ofto
diagnostichydrolyze
resistant
microbiology and
bacteria
microbiology
bacteria carrying enzyme able to hydrolyze and inactivate them. inactivate
from
laboratory a them.
swab
laboratory
in is
in
The HB&L
60 60 Disposable MRSA KIT
Disposable - SI
blueblue 1001.900-L
screw
screw
cap cap (Liquid
vialsvials
withwithSwab)
The research of the presence of resistant bacteria from a swab is
a
order research
practice
order
to quickly
to quickly of
widely the
identify presence
used
identify
and in
isolate
and of resistant
diagnostic
isolate
patients
patientsbacteria
microbiology
with with
serious from
serious a swab
laboratory
infections in
infections
is HB&L MRSA KIT -- SI 1001.900-L (Liquid Swab)
a HB&L 1.8 MRSA
ml
1.8
ofml KIT
culture
of SI
culture 1001.900-L
brothbroth
and and
2D (Liquid
barcode
2D Swab)
barcode
a practice
order
induced
inducedby
practice bywidely
to aggressive
quickly used
identify
aggressive
widely in
in diagnostic
and
pathogens.
used isolate
pathogens.
diagnostic microbiology
Thepatients
The
two twowith
main serious
main
microbiology laboratory
ß-lactamases
ß-lactamases
laboratory in
infections
in 60 Disposable blue screw cap vials with
orderin to quickly identify 1 160 Disposable
1.8 ml
Regenerating of
Regenerating blue
culture
solution screw
broth
solution cap
and vials
2D with
barcode
induced
present
present
order to in
quickly identify and
Enterobacteriaceae
byEnterobacteriaceae
aggressive and isolate
pathogens.
spp. spp. patients
are the
isolate The
are two
ESBLs
the
patients with
ESBLs
withandserious
main and
AmpCs.
serious infections
ß-lactamases
AmpCs.
infections 60 Disposable blue screw cap vials with
1.8 ml
induced
present by
in aggressive
Enterobacteriaceae pathogens.spp. The
are two
the
induced by aggressive pathogens. The two main ß-lactamasesESBLsmain andß-lactamases
AmpCs. 10 110 MRSA MRSAml of culture
Regenerating
1.8 supplement
supplement
of culture broth
broth and
solution and 2D
2D barcode
barcode
1 11 MIC MRSA
10 Regenerating
MIC
Card supplement
Card solution
present
present in in Enterobacteriaceae
Enterobacteriaceae spp. spp. are
are the
the ESBLs
ESBLs and and AmpCs.
AmpCs. Regenerating solution
110
10 MRSA
MIC
MRSA supplement
Card
supplement
HB&L11 MIC
MRSA Card
MIC Card - SI 1001.900 (Dry Swab)
KIT
MRSA
MRSA 60 60 Disposable Disposableblueblue
screw
screw
cap cap
vialsvials
withwith
MRSA
MRSA
Staphylococcus
Staphylococcus aureusaureus
is a iscommon
a common bacteria
bacteria
present
present
on theon the 1
60 2.0 ml
160
2.0
2.0
60 Regenerating
ofml
culture
of culture
Disposable
Disposable
broth
blue
blue
ml of culture
Regenerating
Disposable solution
blue
broth
and and
screw
screw
2D
capbarcode
cap
broth and
solution
screw
2D
vialsbarcode
vials
cap 2D
with
with
vialsbarcode
with
SHELF
SHELF
LIFELIFE STORAGE
STORAGE 10 110 MRSA 2.0 ml of
Regenerating
MRSA culture
supplement
supplement broth
solution and 2D
2.0 ml of culture broth and 2D barcode barcode
skin Staphylococcus
skin
and and
mucousmucous
membranes
membranes
aureus is ina 20-30%
in 20-30%
common of bacteria
healthy
of healthypeople.
people.
present This
on This
the
Staphylococcus
bacteria
bacteria
is known
is
Staphylococcus
skin and known
mucous foraureus
causing is
for causing
aureus
membranes a
a common
is infections in bacteria
ininfections
20-30%
common different present
in healthy
of different
bacteria districts on
districts
people.
present the
of This
on of
the FromSHELF
From
production:
production:
LIFE CONDITIONS
CONDITIONS
STORAGE 1 11 MIC MRSA
10 Regenerating
MIC
CardCard supplement
Regenerating solution
solution
skin and mucous membranes in 20-30% of healthy people. This SHELF
10 months
From
SHELF LIFE
10 months
production:
LIFE STORAGE
Refrigerated
Refrigerated
CONDITIONS
STORAGE 110
10 MRSA
MIC supplement
Card
MRSA supplement
the organism
the organism
bacteria
skin and is asknown
skin,
as skin,
mucous open
foropen
wounds,
wounds,
causing
membranes respiratory
respiratory
ininfections
20-30% inand
of and
urinary
urinary
different
healthy tracts.
people. tracts.
districts of
This
bacteria is known for causing infections in FromFrom production:
10reconstitution: CONDITIONS
reconstitution:temperature
temperature 11 MIC
MIC Card
Some Some
thestrains
strains
iscalled
organism
bacteria called
as
known methicillin-resistant
formethicillin-resistant
skin, open wounds,
causing in different
Staphylococcus
Staphylococcus
respiratory
infections districts
aureus
and urinary
different aureusof
tracts.
districts of From
10
months
production:
months
Refrigerated
CONDITIONS Card
the
(MRSA)
Some
the organism
(MRSA)have have as skin,
developed
strains
organism developed
called
as open wounds,
a resistance
a wounds,
resistance respiratory
torespiratory
skin, methicillin-resistant
open beta-lactam and urinary
to Staphylococcus
beta-lactam
andantibioticstracts.
antibiotics
urinary aureus
tracts. 7 days
7 days
From
10 reconstitution:(+4 Refrigerated
months (+4
8 °C)8 °C)
temperature
Refrigerated
From
7 daysreconstitution: temperature
whichSome
which
(MRSA)
Some strains
are used
are used
have
strains called
in the themethicillin-resistant
in treatment
developed
called treatmentof numerous to Staphylococcus
of numerous
a resistance
methicillin-resistant infections
infections
Staphylococcus
beta-lactam aureus
diseases
diseases
aureus
antibiotics From reconstitution: (+4 8 °C)
temperature
(MRSA) have developed a resistance to beta-lactam antibiotics 7 days
7The
days (+4 8 8 °C)
and (MRSA)
and
therefore
whichtherefore
difficult
arehave
used difficult
in to eradicate.
the
developed to eradicate.
treatment of numerous
a resistance infections
to beta-lactam diseases
antibiotics kits are dedicated(+4 °C) microbiology line analyzers: HB&L Uroquattro, Alfred 60/AST and Sidecar
to ALIFAX The The association
association withwith Sidecar
Sidecar walk-away
walk-away system
system allows
allows the streaking
the streaking of primary
of primary sample
sample or enriched
or enriched culture
culture
which are
are used
and therefore
which used in
in the
difficult treatment
the to eradicate.
treatment of
of numerous
numerous infections
infections diseases
diseases Not forNot
sale
forinsale
U.S. in U.S. in
in total
Thetotal automation.
automation.
association with Sidecar walk-away system allows the streaking of primary sample or enriched culture
and therefore difficult to eradicate.
and therefore difficult to eradicate.
Due toDue
regulatory
to regulatory
requirements,
Not for sale in U.S.
requirements,
the products
the products
listed herein
listed herein
are available
are available
for sale
forinsale
any inrelevant
any relevant
Country
Country
territory
territory
providedprovided
that they
thathave
theybeen
have registered
been registered The association
in total
The with
with Sidecar
automation.
association Sidecar walk-away
walk-away system
system allows
allows the
the streaking
streaking of
of primary
primary sample
sample or
or enriched
enriched culture
culture
according
according
to the toapplicable
the applicable
domestic
domestic
law. The
law.
products
The products
listed herein
listed herein
may have
mayincurred
have incurred
changeschanges
with respect
with respect
to the to
last
the
available
last available
edition.
edition.
Due for
Not to regulatory
sale in U.S.requirements, the products listed herein are available for sale in any relevant Country territory provided that they have been registered
Not for sale in U.S. in total automation.
in total automation.
Due to regulatory
according requirements,
to the applicable the products
domestic law. Thelisted herein
products are herein
listed available
mayforhave
sale incurred
in any relevant
changesCountry territory
with respect toprovided that theyedition.
the last available have been registered
Due to regulatory requirements, the products listed herein are available for sale in any relevant Country territory provided that they have been registered
according to the applicable domestic law. The products listed herein may have incurred changes with respect to the last available edition.
according to the applicable domestic law. The products listed herein may have incurred changes with respect to the last available edition.